Neuroinflammation refers to the inflammation that occurs in the central nervous system (CNS), involving various cells and molecules of the immune system. While inflammation is a normal response to injury or infection in the body, chronic neuroinflammation can have detrimental effects on brain function and contribute to the pathogenesis of numerous neurological disorders. Microglia, the resident immune cells of the CNS, play a key role in neuroinflammation. When activated, microglia release pro-inflammatory molecules such as cytokines, chemokines, and reactive oxygen species, which can lead to damage of neurons and other cells in the brain. Additionally, astrocytes, another type of glial cell, can become activated and contribute to neuroinflammation. Neuroinflammation has been implicated in a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and traumatic brain injury. In these conditions, chronic inflammation exacerbates neuronal damage and accelerates disease progression. Understanding the mechanisms underlying neuroinflammation is crucial for the development of novel therapeutic strategies. Researchers are exploring various approaches to modulate neuroinflammation, including targeting specific inflammatory molecules, regulating immune cell activation, and promoting neuroprotective pathways. These efforts hold promise for the development of treatments that can slow or halt the progression of neuroinflammatory disorders and promote brain health.